Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
- PMID: 26517431
- PMCID: PMC6055926
- DOI: 10.1111/bpa.12336
Diffuse Midline Gliomas with Histone H3-K27M Mutation: A Series of 47 Cases Assessing the Spectrum of Morphologic Variation and Associated Genetic Alterations
Abstract
Somatic mutations of the H3F3A and HIST1H3B genes encoding the histone H3 variants, H3.3 and H3.1, were recently identified in high-grade gliomas arising in the thalamus, pons and spinal cord of children and young adults. However, the complete range of patients and locations in which these tumors arise, as well as the morphologic spectrum and associated genetic alterations remain undefined. Here, we describe a series of 47 diffuse midline gliomas with histone H3-K27M mutation. The 25 male and 22 female patients ranged in age from 2 to 65 years (median = 14). Tumors were centered not only in the pons, thalamus, and spinal cord, but also in the third ventricle, hypothalamus, pineal region and cerebellum. Patients with pontine tumors were younger (median = 7 years) than those with thalamic (median = 24 years) or spinal (median = 25 years) tumors. A wide morphologic spectrum was encountered including gliomas with giant cells, epithelioid and rhabdoid cells, primitive neuroectodermal tumor (PNET)-like foci, neuropil-like islands, pilomyxoid features, ependymal-like areas, sarcomatous transformation, ganglionic differentiation and pleomorphic xanthoastrocytoma (PXA)-like areas. In this series, histone H3-K27M mutation was mutually exclusive with IDH1 mutation and EGFR amplification, rarely co-occurred with BRAF-V600E mutation, and was commonly associated with p53 overexpression, ATRX loss (except in pontine gliomas), and monosomy 10.
Keywords: DIPG; H3F3A; HIST1H3B; K27M mutation; astrocytoma; diffuse intrinsic pontine glioma; diffuse midline glioma; glioblastoma; histone H3.1; histone H3.3.
© 2015 International Society of Neuropathology.
Figures
Similar articles
-
Transcriptomic and epigenetic profiling of 'diffuse midline gliomas, H3 K27M-mutant' discriminate two subgroups based on the type of histone H3 mutated and not supratentorial or infratentorial location.Acta Neuropathol Commun. 2018 Nov 5;6(1):117. doi: 10.1186/s40478-018-0614-1. Acta Neuropathol Commun. 2018. PMID: 30396367 Free PMC article.
-
Characteristics of H3 K27M-mutant gliomas in adults.Neuro Oncol. 2017 Aug 1;19(8):1127-1134. doi: 10.1093/neuonc/now274. Neuro Oncol. 2017. PMID: 28201752 Free PMC article.
-
H3 K27M-mutant diffuse midline gliomas in different anatomical locations.Hum Pathol. 2018 Aug;78:89-96. doi: 10.1016/j.humpath.2018.04.015. Epub 2018 May 1. Hum Pathol. 2018. PMID: 29727696
-
The role of histone modifications and telomere alterations in the pathogenesis of diffuse gliomas in adults and children.J Neurooncol. 2017 Mar;132(1):1-11. doi: 10.1007/s11060-016-2349-9. Epub 2017 Jan 7. J Neurooncol. 2017. PMID: 28064387 Free PMC article. Review.
-
Integrated diagnostics of diffuse astrocytic and oligodendroglial tumors.Pathologe. 2019 Jun;40(Suppl 1):9-17. doi: 10.1007/s00292-019-0581-8. Pathologe. 2019. PMID: 31025086 Review. English.
Cited by
-
Prognostic factors analysis of diffuse midline glioma.J Neurooncol. 2024 Feb 21. doi: 10.1007/s11060-024-04605-6. Online ahead of print. J Neurooncol. 2024. PMID: 38381257
-
Diffuse Midline H3K27-Altered Gliomas in the Spinal Cord: A Systematic Review.J Neurooncol. 2024 Feb;166(3):379-394. doi: 10.1007/s11060-024-04584-8. Epub 2024 Feb 12. J Neurooncol. 2024. PMID: 38342826 Review.
-
H3 K27M mutation in rosette-forming glioneuronal tumors: a potential diagnostic pitfall.Virchows Arch. 2024 Jan 17. doi: 10.1007/s00428-024-03739-2. Online ahead of print. Virchows Arch. 2024. PMID: 38233563
-
Does H3K27M Mutation Impact Survival Outcome of High-Grade Spinal Cord Astrocytoma?Neurospine. 2023 Dec;20(4):1480-1489. doi: 10.14245/ns.2346650.325. Epub 2023 Dec 31. Neurospine. 2023. PMID: 38171314 Free PMC article.
-
A new subtype of diffuse midline glioma, H3 K27 and BRAF/FGFR1 co-altered: a clinico-radiological and histomolecular characterisation.Acta Neuropathol. 2023 Dec 8;147(1):2. doi: 10.1007/s00401-023-02651-4. Acta Neuropathol. 2023. PMID: 38066305 Free PMC article.
References
-
- Bender S, Tang Y, Lindroth AM, Hovestadt V, Jones DT, Kool M et al (2013) Reduced H3K27me3 and DNA hypomethylation are major drivers of gene expression in K27M mutant pediatric high‐grade gliomas. Cancer Cell 24:660–672. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous
